TY - JOUR
T1 - Worldwide anaesthesia use during endovascular treatment for medium vessel occlusion stroke
AU - Kappelhof, Manon
AU - Ospel, Johanna M.
AU - Cimflova, Petra
AU - Kashani, Nima
AU - Singh, Nishita
AU - McDonough, Rosalie
AU - Sehgal, Arshia
AU - Almekhlafi, Mohammed A.
AU - Fiehler, Jens
AU - Chen, Michael
AU - Sakai, Nobuyuki
AU - Majoie, Charles B. LM
AU - Goyal, Mayank
N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MC: consulting (Medtronic, Genentech, Stryker, Microvention, Ceronovus, Penumbra). JF: research support (German Ministries of Science and Education, Economy and Innovation, German Research Foundation, European Union, Hamburgische Investitions-/Förderbank, Medtronic, Microvention, Stryker), consultancy (Acandis, Bayer, Boehringer Ingelheim, Cerenovus, MD Clinicals, Medtronic, Microvention, Penumbra, Phenox, Stryker), managing director (Eppdata), shareholder (Tegus). CM: grants (CVON/Dutch Heart Foundation, TWIN, European Commission, Dutch Health Evaluation program, Stryker); shareholder (Nico.Lab). MG: personal (Mentice, Medtronic, Microvention, Stryker); patent (systems of acute stroke diagnosis). Others: None. Funding Information: MC: consulting (Medtronic, Genentech, Stryker, Microvention, Ceronovus, Penumbra). JF: research support (German Ministries of Science and Education, Economy and Innovation, German Research Foundation, European Union, Hamburgische Investitions-/Förderbank, Medtronic, Microvention, Stryker), consultancy (Acandis, Bayer, Boehringer Ingelheim, Cerenovus, MD Clinicals, Medtronic, Microvention, Penumbra, Phenox, Stryker), managing director (Eppdata), shareholder (Tegus). CM: grants (CVON/Dutch Heart Foundation, TWIN, European Commission, Dutch Health Evaluation program, Stryker); shareholder (Nico.Lab). MG: personal (Mentice, Medtronic, Microvention, Stryker); patent (systems of acute stroke diagnosis). Others: None. Publisher Copyright: © The Author(s) 2021.
PY - 2021
Y1 - 2021
N2 - Introduction: The optimal anaesthesia approach for endovascular treatment (EVT) in acute ischaemic stroke is currently unknown. In stroke due to medium vessel occlusions (MeVO), the occluded vessels are particularly small and more difficult to access, especially in restless or uncooperative patients. In these patients, general anaesthesia (GA) may be preferred by physicians to prevent complications due to patient movement. We investigated physicians’ approaches to anaesthesia during EVT for MeVO stroke. Methods: In a worldwide, case-based, online survey, physicians’ preferred anaesthesia approach during EVT for MeVO stroke was categorized as “initial GA”, “initial GA if necessary” (depending on patient cooperation), “no initial GA, but conversion if necessary” (start with local anaesthesia or conscious sedation), and “no GA”. Preferred anaesthesia approaches were reported overall and stratified by physician and patient characteristics. Results: A total of 366 survey participants provided 1464 responses to 4 primary MeVO EVT case-scenarios. One-third of responses (489/1464 [33%]) favoured no initial GA, but conversion if necessary. Both initial GA and initial GA if necessary were preferred in 368/1464 (25%) of responses respectively. No GA was favoured in 244/1464 (17%). Occlusion location, respondent specialization (interventional neuroradiology), higher age, and female respondent sex were significantly associated with GA preference. GA was more often used in Europe than in other parts of the world (p < 0.001). Conclusions: Anaesthesia approaches in MeVO EVT vary across world regions and patient and physician factors. Most physicians in this survey preferred to start with local anaesthesia or conscious sedation and convert to GA if necessary.
AB - Introduction: The optimal anaesthesia approach for endovascular treatment (EVT) in acute ischaemic stroke is currently unknown. In stroke due to medium vessel occlusions (MeVO), the occluded vessels are particularly small and more difficult to access, especially in restless or uncooperative patients. In these patients, general anaesthesia (GA) may be preferred by physicians to prevent complications due to patient movement. We investigated physicians’ approaches to anaesthesia during EVT for MeVO stroke. Methods: In a worldwide, case-based, online survey, physicians’ preferred anaesthesia approach during EVT for MeVO stroke was categorized as “initial GA”, “initial GA if necessary” (depending on patient cooperation), “no initial GA, but conversion if necessary” (start with local anaesthesia or conscious sedation), and “no GA”. Preferred anaesthesia approaches were reported overall and stratified by physician and patient characteristics. Results: A total of 366 survey participants provided 1464 responses to 4 primary MeVO EVT case-scenarios. One-third of responses (489/1464 [33%]) favoured no initial GA, but conversion if necessary. Both initial GA and initial GA if necessary were preferred in 368/1464 (25%) of responses respectively. No GA was favoured in 244/1464 (17%). Occlusion location, respondent specialization (interventional neuroradiology), higher age, and female respondent sex were significantly associated with GA preference. GA was more often used in Europe than in other parts of the world (p < 0.001). Conclusions: Anaesthesia approaches in MeVO EVT vary across world regions and patient and physician factors. Most physicians in this survey preferred to start with local anaesthesia or conscious sedation and convert to GA if necessary.
KW - Ischemic stroke
KW - anaesthesia
KW - thrombectomy
UR - http://www.scopus.com/inward/record.url?scp=85117272263&partnerID=8YFLogxK
U2 - https://doi.org/10.1177/15910199211041487
DO - https://doi.org/10.1177/15910199211041487
M3 - Article
C2 - 34665059
SN - 1591-0199
JO - Interventional neuroradiology
JF - Interventional neuroradiology
ER -